Invention Grant
- Patent Title: Pazopanib formulation
- Patent Title (中): 帕唑帕尼配方
-
Application No.: US14353141Application Date: 2012-10-16
-
Publication No.: US09278099B2Publication Date: 2016-03-08
- Inventor: Gossett Augustus Campbell , Helen Richardson , Peter A. Williams
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- International Application: PCT/US2012/060361 WO 20121016
- International Announcement: WO2013/066616 WO 20130510
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K47/32 ; A61K47/36 ; A61K47/46 ; A61K9/00 ; A61K9/16 ; A61K9/14
Abstract:
A granulation formulation of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide or pharmaceutically acceptable salt thereof, which is adapted for reconstitution with an aqueous vehicle, and associated oral suspension.
Public/Granted literature
- US20140255505A1 Pazopanib Formulation Public/Granted day:2014-09-11
Information query
IPC分类:
